Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 20th:
Vale S.A. (VALE - Free Report) : This producer and seller of iron ore and iron ore pellets for use as raw materials in steelmaking has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 22.3% over the last 60 days.
Vale has a price-to-earnings ratio (P/E) of 4.18, compared with 6.00 for the industry. The company possesses a Value Score of B.
MetroCity Bankshares, Inc. (MCBS - Free Report) : This bank holding company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 15.8% over the last 60 days.
MetroCity Bankshares has a price-to-earnings ratio (P/E) of 7.50, compared with 12.60 for the industry. The company possesses a Value Score of B.
BCB Bancorp, Inc. (BCBP - Free Report) : This company that provides banking products and services to businesses and individuals has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 26.4% over the last 60 days.
BCB Bancorp has a price-to-earnings ratio (P/E) of 8.97, compared with 11.70 for the industry. The company possesses a Value Score of A.
Atlas Air Worldwide Holdings, Inc. : This outsourced aircraft and aviation operating services provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 55.9% over the last 60 days.
Atlas Air has a price-to-earnings ratio (P/E) of 6.15, compared with 17.80 for the industry. The company possesses a Value Score of A.
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 20th:
Vale S.A. (VALE - Free Report) : This producer and seller of iron ore and iron ore pellets for use as raw materials in steelmaking has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 22.3% over the last 60 days.
Vale has a price-to-earnings ratio (P/E) of 4.18, compared with 6.00 for the industry. The company possesses a Value Score of B.
MetroCity Bankshares, Inc. (MCBS - Free Report) : This bank holding company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 15.8% over the last 60 days.
MetroCity Bankshares has a price-to-earnings ratio (P/E) of 7.50, compared with 12.60 for the industry. The company possesses a Value Score of B.
BCB Bancorp, Inc. (BCBP - Free Report) : This company that provides banking products and services to businesses and individuals has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 26.4% over the last 60 days.
BCB Bancorp has a price-to-earnings ratio (P/E) of 8.97, compared with 11.70 for the industry. The company possesses a Value Score of A.
Atlas Air Worldwide Holdings, Inc. : This outsourced aircraft and aviation operating services provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 55.9% over the last 60 days.
Atlas Air has a price-to-earnings ratio (P/E) of 6.15, compared with 17.80 for the industry. The company possesses a Value Score of A.
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on VALE - FREE
Get the latest research report on BCBP - FREE
Get the latest research report on MCBS - FREE